Evidence map›Paper›PMID 32708657›Full record

ArticleBiomedicines2020

Changes in Circulating Extracellular Vesicles in Patients with ST-Elevation Myocardial Infarction and Potential Effects of Remote Ischemic Conditioning-A Randomized Controlled Trial.

Paul M Haller, Bernhard Jäger, Edita Piackova, Larissa Sztulman, Claudia Wegberger, Johann Wojta, Mariann Gyöngyösi, Attila Kiss, Bruno K Podesser, Andreas Spittler and 1 more

Open access · goldAbstract read
In one paragraph

Article in Biomedicines, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Review
  3. Observational
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Paul M Haller3rd Department of Medicine, Cardiology and Intensive Care Medicine, Wilhelminenhospital, 1160 Vienna, Austria.ORCID 0000-0002-7714-4446
Bernhard Jäger3rd Department of Medicine, Cardiology and Intensive Care Medicine, Wilhelminenhospital, 1160 Vienna, Austria.
Edita Piackova3rd Department of Medicine, Cardiology and Intensive Care Medicine, Wilhelminenhospital, 1160 Vienna, Austria.
Larissa Sztulman3rd Department of Medicine, Cardiology and Intensive Care Medicine, Wilhelminenhospital, 1160 Vienna, Austria.
Claudia Wegberger3rd Department of Medicine, Cardiology and Intensive Care Medicine, Wilhelminenhospital, 1160 Vienna, Austria.
Johann WojtaLudwig Boltzmann Institute for Cardiovascular Research, 1160 Vienna, Austria.
Mariann GyöngyösiDepartment of Internal Medicine II, Division of Cardiology, Medical University of Vienna, 1090 Vienna, Austria.ORCID 0000-0002-7083-2107
Attila KissLudwig Boltzmann Institute for Cardiovascular Research, 1160 Vienna, Austria.ORCID 0000-0003-4652-1998
Bruno K PodesserLudwig Boltzmann Institute for Cardiovascular Research, 1160 Vienna, Austria.ORCID 0000-0002-4641-7202
Andreas SpittlerCore Facility, Medical University of Vienna, 1090 Vienna, Austria.ORCID 0000-0003-2657-6836
Kurt Huber3rd Department of Medicine, Cardiology and Intensive Care Medicine, Wilhelminenhospital, 1160 Vienna, Austria.
Wilhelminen Hospital · ATLudwig Boltzmann Institute for Cancer Research · ATMedical University of Vienna · ATSigmund Freud Privatuniversität Wien · AT

Funding

Association for Research on Arteriosclerosis, Thrombosis and Vascular Biology (ATVB) N/ALudwig Boltzmann Institute for Cardiovascular Research N/AMedical Scientific Fund of the Mayor of the City of Vienna 17091
6 · The paper itself

Abstract

(1) Background: Extracellular vesicles (EVs) have been recognized as a cellular communication tool with cardioprotective properties; however, it is unknown whether cardioprotection by remote ischemic conditioning (RIC) involves EVs. (2) Methods: We randomized patients with ST-elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PCI) to additionally receive a protocol of RIC or a sham-intervention. Blood was taken before and immediately, 24 h, four days and one month after PCI. Additionally, we investigated EVs from healthy volunteers undergoing RIC. EVs were characterized by a high-sensitive flow cytometer (Beckman Coulter Cytoflex S, Krefeld, Germany). (3) Results: We analyzed 32 patients (16 RIC, 16 control) and five healthy volunteers. We investigated platelet-, endothelial-, leukocyte-, monocyte- and granulocyte-derived EVs and their pro-thrombotic sub-populations expressing superficial phosphatidylserine (PS

Indexed as

cardioprotectionextracellular vesiclesflow cytometrymyocardial infarctionremote ischemic conditioning

Identifiers

PMID32708657
PMCPMC7400268
OpenAlexW3042243664

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.